Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up immunogenicity study after FE 999905 CS07 in children treated with daily ZOMACTON or GENOTROPIN
2014-000627-24Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- May 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of somatropin in idiopathic growth hormone deficiency (I-GHD), sponsored by Ferring Pharmaceuticals. Started May 2014; status: completed.
02
Drugs
somatropin
03
Conditions
idiopathic growth hormone deficiency (I-GHD)
Beyond the preview
Go deeper on 2014-000627-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000627-24.